OHSU's HIV vaccine nears clinical trial
A promising HIV vaccine developed at Oregon Health& Science University is getting closer to human clinical trials.
Dr. Louis Picker, a professor at OHSU’s Vaccine& Gene Therapy Institute, said his lab has tested a weakened version of the vaccine in monkeys that provides similar protection to the original, stronger version.
Developing a weaker, or “live-attenuated,” version is important to ensure safety for people with weakened immune systems, Picker said.
The new version eliminated SIV,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
More News: Clinical Trials | Gene Therapy | Genetics | Health Management | Pharmaceuticals | Science | Vaccines